Wilson’s disease treatment market is expected to witness a robust CAGR of 6.0%

The Global Wilson’s Disease Treatment market was valued at US$ 392.0 million in 2016 and is projected to expand at a CAGR of 6.0% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Rampant increase in incidence rate of Wilson’s disease inadvertently fuels growth of the market.

Manufacturers are focusing on drug innovation to tap into emerging markets of Asia Pacific, given their increasing spending on healthcare. For instance, Valeant Pharmaceuticals International Inc. announced the support regarding Wilson’s disease by providing US$ 100,000 fund for patient awareness and research into the treatment of Wilson’s disease. Whereas, Valeant Pharmaceuticals International. Inc. also sells its medication for Wilson’s disease under the Valeant coverage plus policy that assists customers to identify the best cost saving options. Furthermore, small manufacturers are launching tablets for Wilson’s disease under the licensed agreement with big manufacturers for example, Noblepharma Co., Ltd. Launched Nobelzin tablets under the licensed agreement with TEVA Pharmaceuticals.

Furthermore, manufacturers are also involved in R&D for novel drugs and vaccine. For instance in 2016, Merck & Co., Inc. invested US$6.8 Bn on research and development.

Request a sample copy of this [email protected]

https://www.coherentmarketinsights.com/insight/request-sample/526

It is expected that the increase in population prevalence will favor the growth of Wilson’s disease treatment market in the near future. Especially, in countries such as China and India where there is a rapid increase in the population. Growth in awareness and increased expenditure on healthcare is also expected to fuel growth of the Wilson’s disease treatment market. Wilson disease is caused by an inherited autosomal recessive mutation and in an autosomal recessive disease the child has to inherit the gene mutation from both parents which increases the likelihood for the disease as the chance of inheriting autosomal recessive mutations from parent with gene mutation is one in four or 25%.  Furthermore, both men and women develop Wilson’s disease at equal rate and symptoms for Wilson’s disease appear between age 5 to 35 but however new cases have been reported between age of 3 to 72 years.

Wilson’s disease can be treated by various medications such as D-Penicillamine, trientine, zinc, tetrathiomolybdate. Change in diet and nutrition with medications can also help to treat the Wilson’s disease. Liver transplantation is necessary if cirrhosis leads to liver failure or acute liver failure. Else liver transplantation is also done if any other treatment is not effective to treat Wilson’s disease.

Key take aways of the market:

The global Wilson’s disease treatment market is expected to expand at a CAGR of 6.0% during the forecast period (2017–2025). Due to rising awareness regarding Wilson’s disease around the globe is expected to favor growth of the market of Wilson’s disease treatment over the forecast period.

The Asia Pacific Wilson’s disease treatment market is expected to show high growth rate during the forecast period in terms of value

Among treatment types, medication segment is expected to expand at a significant CAGR of 6.0% over the forecast period. This is mainly attributed to increasing adoption of D-penicillamine, owing to its wide availability and high efficacy

The global Wilson’s disease treatment market is characterized by market expansion in Asia Pacific, North America, and Europe could generate higher market revenue due to increase in population

Some of the major companies offering Wilson’s disease treatments are Valeant Pharmaceuticals, Wilson therapeutics, tsumura & Co., Merck & Co., VHB Life Science Inc., and Teva Pharmaceuticals USA, Inc.

Ask For Customization@

https://www.coherentmarketinsights.com/insight/request-customization/526

You may be interested

New Study Links Plastic Degradation to Emission of Greenhouse Gases
Business
Business

New Study Links Plastic Degradation to Emission of Greenhouse Gases

Mohit Joshi - December 12, 2018

Researchers from University of Hawaii at Manoa revealed that degradation of plastic leads to emission of several greenhouse gases. Plastic is a widely used material, owing to…

Business

Hearing Aid Market Segmented by Type, Market Demand Industry Growth, Trends and Forecasts 2018 to 2023

Albert R - December 11, 2018

Worldwide Market Reports recently released "Hearing Aid Market Report 2017 to 2023". Most recent market Value and Sales Price in the Hearing Aid Market report classifies the…

Business

Hair drier 2018 – 2023 Future Demand Analysis, Industry sizes, competition, Market overviews

Albert R - December 11, 2018

Worldwide Market Reports recently released "Hair drier Market Report 2017 to 2023". Most recent market Value and Sales Price in the Hair drier Market report classifies the…

Most from this category